Nov 24, 2008 - Biovail Corporation today announced that Xenazine tablets, an orphan drug recently approved by the U.S. FDA for the treatment of chorea associated with Huntington's disease (HD), is now available throughout the United States.
The details can be read here.
No comments:
Post a Comment